Vaccination in inflammatory bowel disease patients: Attitudes, Knowledge, and Uptake

Journal of Crohn's and Colitis

Volumn 9, Issue 6, 2015, Pages 439-444

  Malhi, Gurtej ^a,b   Rumman, Amir ^b   Thanabalan, Reka ^a   Croitoru, Kenneth ^a,b   Silverberg, Mark S ^a,b   Hillary Steinhart, A ^a,b   Nguyen, Geoffrey C ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

IBD; vaccination; vaccination uptake

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; STEROID; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; COLITIS; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; GASTROENTEROLOGIST; GENERAL PRACTITIONER; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDETERMINATE COLITIS; INFECTION RISK; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PREVALENCE; PRIORITY JOURNAL; TERTIARY CARE CENTER; ULCERATIVE COLITIS; VACCINATION; ADVERSE EFFECTS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; CHICKENPOX VACCINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HERPES ZOSTER VACCINE; HUMANS; INFLAMMATORY BOWEL DISEASES; INFLUENZA VACCINES; MALE; MENINGOCOCCAL VACCINES; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMOCOCCAL VACCINES; SURVEYS AND QUESTIONNAIRES; VACCINATION; VACCINES; YOUNG ADULT;

EID: 84963732946     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv064     Document Type: Article

References (27)

1. Melmed G, Ippoliti A, Papadakis K. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006;101:1834-40.
2. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunisations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004;10:677-92.
3. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis 2009;15:1410-6.
4. Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014;8:443-68.
5. Desalermos AP, Farraye FA, Wasan SK. Vaccinating the inflammatory bowel disease patient. Exp Rev Gastroenterol Hepatol 2014;27:1-12.
6. Narula N, Dhillon AS, Chauhan U, Marshall JK. An audit of influenza vaccination status in adults with inflammatory bowel disease. Can J Gastroenterol 2012;26:593-6.
7. Vermeire S, Van Assche G, Rutgeerts P. Vaccination and infection prevention in inflammatory bowel disease. Med Rep 2010;2:80.
8. Wasan SK, Calderwood AH, Long MD, et al. Immunisation rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis 2014;20:246-50.
9. Banaszkiewicz A, Klincewicz B, Lazowska-Przeorek I, et al. Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respir Viruses 2014;8:431-5.
10. Breglio KJ, Rosh JR. Health maintenance and vaccination strategies in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1740-4.
11. Yun HS, Min YW, Chang DK, et al. Factors associated with vaccination among inflammatory bowel disease patients in Korea. Korean J Gastroenterol 2013;61:203-8.
12. Kim SB, Park SJ, Chung SH, et al. Vaccination and complementary and alternative medicine in patients with inflammatory bowel disease. Intest Re 2014;12:124-30.
13. Gupta A, Macrae FA, Gibson PR. Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists. Intern Med J 2011;41:462-7.
14. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis 2011;17:2536-40.
15. Jung YS, Park JH, Kim HJ, et al. Insufficient knowledge of Korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease. Gut Liver 2014;8:242-7.
16. Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 2001;7:327.
17. Leung VS, Nguyen MT, Bush TM. Disseminated primary varicella after initiation of infliximab for Crohn's disease. Am J Gastroenterol 2004;99:2503-4.
18. Schneeweiss S, Korzenik J, Solomon DH, et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther 2009;30:253-64.
19. Lawrance IC, Radford-Smith GL, Bampton PA, et al. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosisfactor-alpha therapy: an Australian and New Zealand experience. J Gastroenterol Hepatol 2010;25:1732-8.
20. Ali T, Yun L, Shapiro D, Madhoun MF, Bronze M. Viral infections in patients with inflammatory bowel disease on immunosuppressants. Am J Med Sci 2012;343:227-32.
21. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010;105:1231-8.
22. Selby L, Hoellein A, Wilson JF. Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients? Dig Dis Sci 2011;56:819-24.
23. Gutierrez A. Coordinating preventive medicine in patients with inflammatory bowel disease: whose responsibility is it anyway? Clin Gastroenterol Hepatol 2009;7:500-1.
24. Sinclair JA, Wasan SK, Farraye FA. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin North Am 2012;41:325-37.
25. Goff SL, Mazor KM, Gagne SJ, Corey KC, Blake DR. Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine. Vaccine 2011;29:7343-9.
26. Nguyen GC, Devlin SM, Afif W, et al. Defining quality indicators for bestpractice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol 2014;28:275-85.
27. American Gastroenterological Association. Adult Inflammatory Bowel Disease Physician Performance Measures Set: American Gastroenterological Association, 2011. www.ama-assn.org/resources/doc/pcpi/inflammatory-bowel-disease.pdf [Accessed March 12, 2015].